ChronoScale vs Hongli
CHRN and HLP side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CHRN | HLP |
|---|---|---|
| Size and price | ||
| Share price | $9.95 | $4.12 |
| Change, 1 year | 82.6% | 141% |
| Change, 5 years | −80.5% | – |
| Beta (5Y) | 1.27 | −0.09 |
| Employees | – | 176 |
| StockData Score | ||
| Total score | – | 8 |
| Valuation score | – | 0 |
| Growth score | – | 2 |
| Performance score | – | 2 |
| Health score | – | 4 |
| Dividend score | – | 0 |
| Growth | ||
| Revenue growth (TTM) | – | 39.0% |
| Revenue growth, 5Y average | – | 11.9% |
| EPS growth, 5Y average | – | −34.0% |
| Profitability | ||
| Gross margin | – | 32.5% |
| Operating margin | – | 12.4% |
| Net margin | – | 9.9% |
| FCF margin | – | 3.4% |
| Return on equity | – | 3.5% |
| Return on invested capital | – | 3.8% |
| Financial health | ||
| Debt / equity | – | 0.06 |
| Net debt / EBITDA | – | 0.66 |
| Interest coverage | – | 14.7× |
| Current ratio | – | 1.12 |
| Piotroski F-score | – | 5 |
| Ownership | ||
| Held by institutions | 0.73% | – |
| Held by insiders | 100% | 0.00% |
| Insider net buying, 12 months | $1.2M | – |
| Short interest, % of float | – | 0.52% |
Go deeper
- CHRN stock overview
- CHRN income statement
- CHRN valuation and score
- HLP stock overview
- HLP income statement
- HLP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.